

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | central nervous system myelination (GO:0022010) | 8.99781256 |
| 2 | axon ensheathment in central nervous system (GO:0032291) | 8.99781256 |
| 3 | actin-myosin filament sliding (GO:0033275) | 8.94688941 |
| 4 | muscle filament sliding (GO:0030049) | 8.94688941 |
| 5 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 8.29624178 |
| 6 | actin-mediated cell contraction (GO:0070252) | 7.29990416 |
| 7 | skeletal muscle contraction (GO:0003009) | 6.95620100 |
| 8 | regulation of skeletal muscle contraction (GO:0014819) | 6.77682189 |
| 9 | fatty acid elongation (GO:0030497) | 6.18344044 |
| 10 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 6.00246717 |
| 11 | regulation of relaxation of muscle (GO:1901077) | 5.75324215 |
| 12 | striated muscle contraction (GO:0006941) | 5.74785031 |
| 13 | ensheathment of neurons (GO:0007272) | 5.74030133 |
| 14 | axon ensheathment (GO:0008366) | 5.74030133 |
| 15 | myelination (GO:0042552) | 5.73752286 |
| 16 | actin filament-based movement (GO:0030048) | 5.47148980 |
| 17 | myofibril assembly (GO:0030239) | 5.32286499 |
| 18 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 5.30389744 |
| 19 | skeletal muscle fiber development (GO:0048741) | 5.09799659 |
| 20 | response to muscle activity (GO:0014850) | 4.98424624 |
| 21 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 4.96390646 |
| 22 | sarcomere organization (GO:0045214) | 4.93817022 |
| 23 | long-chain fatty acid biosynthetic process (GO:0042759) | 4.85689815 |
| 24 | cardiac muscle contraction (GO:0060048) | 4.78322655 |
| 25 | regulation of cell communication by electrical coupling (GO:0010649) | 4.73617969 |
| 26 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 4.71721732 |
| 27 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.58338070 |
| 28 | muscle contraction (GO:0006936) | 4.46942694 |
| 29 | plasma membrane repair (GO:0001778) | 4.44045803 |
| 30 | myotube cell development (GO:0014904) | 4.43084489 |
| 31 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 4.42825952 |
| 32 | cardiac myofibril assembly (GO:0055003) | 4.35306264 |
| 33 | regulation of actin filament-based movement (GO:1903115) | 4.32634618 |
| 34 | response to inactivity (GO:0014854) | 4.30179234 |
| 35 | cholesterol biosynthetic process (GO:0006695) | 4.21252463 |
| 36 | myelin maintenance (GO:0043217) | 4.19733518 |
| 37 | negative regulation of neurotransmitter transport (GO:0051589) | 4.10312439 |
| 38 | oligodendrocyte differentiation (GO:0048709) | 4.08823857 |
| 39 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.07872726 |
| 40 | negative regulation of neurotransmitter secretion (GO:0046929) | 4.05734367 |
| 41 | creatine metabolic process (GO:0006600) | 4.04387635 |
| 42 | L-amino acid import (GO:0043092) | 4.03501799 |
| 43 | glycogen catabolic process (GO:0005980) | 4.01095631 |
| 44 | muscle system process (GO:0003012) | 3.98584709 |
| 45 | negative regulation of protein localization to cell surface (GO:2000009) | 3.95044118 |
| 46 | NADH metabolic process (GO:0006734) | 3.89925266 |
| 47 | actomyosin structure organization (GO:0031032) | 3.84383431 |
| 48 | eye photoreceptor cell differentiation (GO:0001754) | 3.83512729 |
| 49 | photoreceptor cell differentiation (GO:0046530) | 3.83512729 |
| 50 | presynaptic membrane organization (GO:0097090) | 3.77162444 |
| 51 | neuronal action potential propagation (GO:0019227) | 3.76941777 |
| 52 | establishment of mitochondrion localization (GO:0051654) | 3.76697869 |
| 53 | substantia nigra development (GO:0021762) | 3.74309602 |
| 54 | glucan catabolic process (GO:0009251) | 3.72697305 |
| 55 | cardiac muscle hypertrophy (GO:0003300) | 3.71973247 |
| 56 | presynaptic membrane assembly (GO:0097105) | 3.70430409 |
| 57 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.68270501 |
| 58 | sterol biosynthetic process (GO:0016126) | 3.67518201 |
| 59 | skeletal muscle adaptation (GO:0043501) | 3.64214475 |
| 60 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.60043068 |
| 61 | muscle fiber development (GO:0048747) | 3.59896133 |
| 62 | neuron cell-cell adhesion (GO:0007158) | 3.59643372 |
| 63 | cellular potassium ion homeostasis (GO:0030007) | 3.59090452 |
| 64 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.56669116 |
| 65 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.56669116 |
| 66 | apical protein localization (GO:0045176) | 3.55222068 |
| 67 | striated muscle hypertrophy (GO:0014897) | 3.54386502 |
| 68 | neuromuscular synaptic transmission (GO:0007274) | 3.54014434 |
| 69 | astrocyte development (GO:0014002) | 3.53548041 |
| 70 | glycerophospholipid catabolic process (GO:0046475) | 3.51655885 |
| 71 | glucan biosynthetic process (GO:0009250) | 3.49988350 |
| 72 | glycogen biosynthetic process (GO:0005978) | 3.49988350 |
| 73 | skeletal muscle tissue development (GO:0007519) | 3.47172167 |
| 74 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.45726953 |
| 75 | asymmetric protein localization (GO:0008105) | 3.45491372 |
| 76 | peripheral nervous system axon ensheathment (GO:0032292) | 3.45107375 |
| 77 | myelination in peripheral nervous system (GO:0022011) | 3.45107375 |
| 78 | muscle cell cellular homeostasis (GO:0046716) | 3.44551495 |
| 79 | cellular polysaccharide catabolic process (GO:0044247) | 3.43754016 |
| 80 | regulation of collateral sprouting (GO:0048670) | 3.41459725 |
| 81 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.40093056 |
| 82 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 3.38879807 |
| 83 | sodium ion export (GO:0071436) | 3.38055982 |
| 84 | positive regulation of synapse maturation (GO:0090129) | 3.36718737 |
| 85 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 3.36511411 |
| 86 | transmission of nerve impulse (GO:0019226) | 3.36172308 |
| 87 | striated muscle adaptation (GO:0014888) | 3.35366119 |
| 88 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.35304160 |
| 89 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.35253735 |
| 90 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.35253735 |
| 91 | amino acid import (GO:0043090) | 3.31736565 |
| 92 | response to methylmercury (GO:0051597) | 3.26091455 |
| 93 | response to redox state (GO:0051775) | 3.26036621 |
| 94 | regulation of striated muscle contraction (GO:0006942) | 3.24693964 |
| 95 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 3.23498157 |
| 96 | synaptic vesicle maturation (GO:0016188) | 3.23087537 |
| 97 | positive regulation of myotube differentiation (GO:0010831) | 3.23008157 |
| 98 | gluconeogenesis (GO:0006094) | 3.22104175 |
| 99 | negative regulation of axonogenesis (GO:0050771) | 3.19074011 |
| 100 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.17928778 |
| 101 | isoprenoid biosynthetic process (GO:0008299) | 3.16793864 |
| 102 | adult walking behavior (GO:0007628) | 3.13956926 |
| 103 | regulation of the force of heart contraction (GO:0002026) | 3.11146564 |
| 104 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.07780181 |
| 105 | muscle hypertrophy in response to stress (GO:0003299) | 3.07780181 |
| 106 | cardiac muscle adaptation (GO:0014887) | 3.07780181 |
| 107 | relaxation of muscle (GO:0090075) | 3.07344570 |
| 108 | muscle hypertrophy (GO:0014896) | 3.07177688 |
| 109 | regulation of membrane repolarization (GO:0060306) | 3.06586909 |
| 110 | polysaccharide catabolic process (GO:0000272) | 3.05429368 |
| 111 | cerebral cortex radially oriented cell migration (GO:0021799) | 3.04505622 |
| 112 | 2-oxoglutarate metabolic process (GO:0006103) | 3.00500661 |
| 113 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.99210426 |
| 114 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 2.98389181 |
| 115 | muscle organ development (GO:0007517) | 2.97446750 |
| 116 | import into cell (GO:0098657) | 2.95731763 |
| 117 | muscle structure development (GO:0061061) | 2.94909156 |
| 118 | cerebellar granule cell differentiation (GO:0021707) | 2.93778612 |
| 119 | fructose metabolic process (GO:0006000) | 2.93373736 |
| 120 | postsynaptic membrane organization (GO:0001941) | 2.93352477 |
| 121 | cell communication by electrical coupling (GO:0010644) | 2.92734674 |
| 122 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 2.92164973 |
| 123 | regulation of skeletal muscle cell differentiation (GO:2001014) | 2.92063739 |
| 124 | potassium ion import (GO:0010107) | 2.91780707 |
| 125 | synaptic vesicle exocytosis (GO:0016079) | 2.91494308 |
| 126 | neuronal ion channel clustering (GO:0045161) | 2.90889019 |
| 127 | membrane tubulation (GO:0097320) | 2.89684329 |
| 128 | glutamate secretion (GO:0014047) | 2.88504874 |
| 129 | myoblast fusion (GO:0007520) | 2.87994740 |
| 130 | hexose biosynthetic process (GO:0019319) | 2.86200877 |
| 131 | virion attachment to host cell (GO:0019062) | 2.85424165 |
| 132 | adhesion of symbiont to host cell (GO:0044650) | 2.85424165 |
| 133 | negative regulation of axon extension (GO:0030517) | 2.85205708 |
| 134 | glycogen metabolic process (GO:0005977) | 2.84301410 |
| 135 | dendritic spine morphogenesis (GO:0060997) | 2.84010023 |
| 136 | negative regulation of muscle contraction (GO:0045932) | 2.83542290 |
| 137 | neuron recognition (GO:0008038) | 2.82694290 |
| 138 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.82439557 |
| 139 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.81895960 |
| 140 | regulation of synaptic vesicle transport (GO:1902803) | 2.79075886 |
| 141 | muscle tissue morphogenesis (GO:0060415) | 2.79067644 |
| 142 | tricarboxylic acid cycle (GO:0006099) | 2.77786610 |
| 143 | skeletal muscle tissue regeneration (GO:0043403) | 2.77744655 |
| 144 | regulation of sodium ion transmembrane transport (GO:1902305) | 2.77622140 |
| 145 | regulation of synapse maturation (GO:0090128) | 2.77317898 |
| 146 | glucan metabolic process (GO:0044042) | 2.77255178 |
| 147 | cellular glucan metabolic process (GO:0006073) | 2.77255178 |
| 148 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 2.75136694 |
| 149 | neurotransmitter uptake (GO:0001504) | 2.74877271 |
| 150 | protein palmitoylation (GO:0018345) | 2.72317845 |
| 151 | locomotory exploration behavior (GO:0035641) | 2.70089346 |
| 152 | limb bud formation (GO:0060174) | 2.69491424 |
| 153 | axon development (GO:0061564) | 2.68512918 |
| 154 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 2.67968109 |
| 155 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 2.67968109 |
| 156 | response to lipoprotein particle (GO:0055094) | 2.66057770 |
| 157 | amyloid precursor protein metabolic process (GO:0042982) | 2.65220120 |
| 158 | cellular response to epinephrine stimulus (GO:0071872) | 2.63583716 |
| 159 | magnesium ion transport (GO:0015693) | 2.62938343 |
| 160 | axonal fasciculation (GO:0007413) | 2.62083456 |
| 161 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.59221755 |
| 162 | neural nucleus development (GO:0048857) | 2.57354235 |
| 163 | dendrite morphogenesis (GO:0048813) | 2.57070719 |
| 164 | neuron remodeling (GO:0016322) | 2.53439008 |
| 165 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.53253932 |
| 166 | nerve growth factor signaling pathway (GO:0038180) | 2.52990182 |
| 167 | peripheral nervous system development (GO:0007422) | 2.50937982 |
| 168 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.50811879 |
| 169 | fatty-acyl-CoA metabolic process (GO:0035337) | 2.50655734 |
| 170 | positive regulation of action potential (GO:0045760) | 2.49868822 |
| 171 | cellular response to monoamine stimulus (GO:0071868) | 2.46046690 |
| 172 | cellular response to catecholamine stimulus (GO:0071870) | 2.46046690 |
| 173 | response to epinephrine (GO:0071871) | 2.45876413 |
| 174 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.43285481 |
| 175 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.43234186 |
| 176 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.39938575 |
| 177 | glial cell differentiation (GO:0010001) | 2.39859576 |
| 178 | membrane assembly (GO:0071709) | 2.39325926 |
| 179 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.38335992 |
| 180 | protein localization to synapse (GO:0035418) | 2.37218387 |
| 181 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.36867678 |
| 182 | peptidyl-cysteine modification (GO:0018198) | 2.36466543 |
| 183 | L-serine transport (GO:0015825) | 2.36125600 |
| 184 | glycosylceramide metabolic process (GO:0006677) | 2.35413369 |
| 185 | long-term synaptic potentiation (GO:0060291) | 2.34593691 |
| 186 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.33470944 |
| 187 | adult locomotory behavior (GO:0008344) | 2.32191662 |
| 188 | very long-chain fatty acid metabolic process (GO:0000038) | 2.30908300 |
| 189 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.30567019 |
| 190 | acyl-CoA biosynthetic process (GO:0071616) | 2.30511738 |
| 191 | thioester biosynthetic process (GO:0035384) | 2.30511738 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.44036659 |
| 2 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 3.40599735 |
| 3 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.23145369 |
| 4 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.83152332 |
| 5 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.81948984 |
| 6 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.77442600 |
| 7 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.56644938 |
| 8 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.51191794 |
| 9 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.50933116 |
| 10 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.50933116 |
| 11 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.46918747 |
| 12 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.38966567 |
| 13 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.38463421 |
| 14 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.38352439 |
| 15 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.37313564 |
| 16 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.34907720 |
| 17 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.33452005 |
| 18 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.29113797 |
| 19 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.27688742 |
| 20 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 2.24482784 |
| 21 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.18316426 |
| 22 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.16526988 |
| 23 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.12084692 |
| 24 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.06280063 |
| 25 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.01530172 |
| 26 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.97166400 |
| 27 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.95660707 |
| 28 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.93780864 |
| 29 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.93780864 |
| 30 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.91178226 |
| 31 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.82728687 |
| 32 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.82701825 |
| 33 | * CTCF_27219007_Chip-Seq_Bcells_Human | 1.77694498 |
| 34 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.77184349 |
| 35 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.75527300 |
| 36 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.74845070 |
| 37 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.71044052 |
| 38 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.70578091 |
| 39 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.69793212 |
| 40 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.67108576 |
| 41 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.66858720 |
| 42 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.66324873 |
| 43 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.62930707 |
| 44 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.62560238 |
| 45 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.62029870 |
| 46 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.60708084 |
| 47 | KDM2B_26808549_Chip-Seq_K562_Human | 1.56893838 |
| 48 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.54959078 |
| 49 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.52568265 |
| 50 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.52214274 |
| 51 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.52043583 |
| 52 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.46657661 |
| 53 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.45126087 |
| 54 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.43916747 |
| 55 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.42506200 |
| 56 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.37364723 |
| 57 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.36504624 |
| 58 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.33388168 |
| 59 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.33262233 |
| 60 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.33034701 |
| 61 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.31966135 |
| 62 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.29738489 |
| 63 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.29235484 |
| 64 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.28532986 |
| 65 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.27887920 |
| 66 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.27406273 |
| 67 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.27307435 |
| 68 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.24479196 |
| 69 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.24163962 |
| 70 | VDR_22108803_ChIP-Seq_LS180_Human | 1.24087069 |
| 71 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.22533447 |
| 72 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.21990954 |
| 73 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.21521660 |
| 74 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.20846698 |
| 75 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.19862430 |
| 76 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.19453024 |
| 77 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.19315430 |
| 78 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.19304258 |
| 79 | P300_19829295_ChIP-Seq_ESCs_Human | 1.18598604 |
| 80 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.18503384 |
| 81 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.16829323 |
| 82 | * SMC4_20622854_ChIP-Seq_HELA_Human | 1.16531670 |
| 83 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.16467061 |
| 84 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.16339816 |
| 85 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.15376804 |
| 86 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.14205795 |
| 87 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.13930730 |
| 88 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.13175575 |
| 89 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.12072433 |
| 90 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.11698272 |
| 91 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.11307582 |
| 92 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.10868919 |
| 93 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.10359079 |
| 94 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.09524994 |
| 95 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.09436527 |
| 96 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.09290481 |
| 97 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.09254270 |
| 98 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.08979549 |
| 99 | * TP53_23651856_ChIP-Seq_MEFs_Mouse | 1.08216339 |
| 100 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.07926115 |
| 101 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.06810410 |
| 102 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.05721972 |
| 103 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.05721972 |
| 104 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.05495752 |
| 105 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.04975675 |
| 106 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.03942626 |
| 107 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.03708459 |
| 108 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.03601311 |
| 109 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.03206687 |
| 110 | STAT3_23295773_ChIP-Seq_U87_Human | 1.03200268 |
| 111 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.03028088 |
| 112 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.03001298 |
| 113 | P68_20966046_ChIP-Seq_HELA_Human | 1.02877245 |
| 114 | FUS_26573619_Chip-Seq_HEK293_Human | 1.02436747 |
| 115 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.02259470 |
| 116 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 1.02009502 |
| 117 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.01800539 |
| 118 | * SA1_27219007_Chip-Seq_Bcells_Human | 1.01180424 |
| 119 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.00249268 |
| 120 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.99547016 |
| 121 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.99368865 |
| 122 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.99180744 |
| 123 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.97812091 |
| 124 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.97684709 |
| 125 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.97613291 |
| 126 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.97236523 |
| 127 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.96032952 |
| 128 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.95701727 |
| 129 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.95630536 |
| 130 | SOX9_26525672_Chip-Seq_Limbbuds_Mouse | 0.94999340 |
| 131 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 0.94849018 |
| 132 | * RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.94751491 |
| 133 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.93163163 |
| 134 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.92592503 |
| 135 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.92042770 |
| 136 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.91987612 |
| 137 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.91886004 |
| 138 | TCF4_23295773_ChIP-Seq_U87_Human | 0.91668874 |
| 139 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.91516258 |
| 140 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.91191661 |
| 141 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.91109349 |
| 142 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.90738284 |
| 143 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.90580498 |
| 144 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.90434741 |
| 145 | * PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.89957136 |
| 146 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.89726726 |
| 147 | * OCT4_19829295_ChIP-Seq_ESCs_Human | 0.89559480 |
| 148 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.89362734 |
| 149 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.88824928 |
| 150 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.88764316 |
| 151 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.87083708 |
| 152 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.86139330 |
| 153 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.85335524 |
| 154 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.85171960 |
| 155 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.85121268 |
| 156 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.84325943 |
| 157 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.83561227 |
| 158 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.83334202 |
| 159 | AR_25329375_ChIP-Seq_VCAP_Human | 0.82190419 |
| 160 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.81427019 |
| 161 | TP53_16413492_ChIP-PET_HCT116_Human | 0.81394085 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003646_muscle_fatigue | 5.23339441 |
| 2 | MP0000920_abnormal_myelination | 4.13590486 |
| 3 | MP0003880_abnormal_central_pattern | 4.03604060 |
| 4 | MP0004859_abnormal_synaptic_plasticity | 3.63388217 |
| 5 | MP0004270_analgesia | 3.60879217 |
| 6 | MP0002106_abnormal_muscle_physiology | 3.10571209 |
| 7 | MP0000759_abnormal_skeletal_muscle | 3.06317890 |
| 8 | MP0004087_abnormal_muscle_fiber | 2.92061395 |
| 9 | MP0003329_amyloid_beta_deposits | 2.90697806 |
| 10 | MP0005369_muscle_phenotype | 2.65741199 |
| 11 | MP0002332_abnormal_exercise_endurance | 2.60663614 |
| 12 | MP0004130_abnormal_muscle_cell | 2.60255516 |
| 13 | MP0003690_abnormal_glial_cell | 2.59411516 |
| 14 | MP0001486_abnormal_startle_reflex | 2.58203484 |
| 15 | MP0004233_abnormal_muscle_weight | 2.55164206 |
| 16 | MP0002269_muscular_atrophy | 2.53431907 |
| 17 | MP0002064_seizures | 2.53109485 |
| 18 | MP0002272_abnormal_nervous_system | 2.52922848 |
| 19 | MP0000750_abnormal_muscle_regeneration | 2.50862805 |
| 20 | MP0003635_abnormal_synaptic_transmissio | 2.50234043 |
| 21 | MP0005620_abnormal_muscle_contractility | 2.44675004 |
| 22 | MP0004084_abnormal_cardiac_muscle | 2.44300495 |
| 23 | MP0004885_abnormal_endolymph | 2.36300730 |
| 24 | MP0003950_abnormal_plasma_membrane | 2.34472204 |
| 25 | MP0000778_abnormal_nervous_system | 2.26778737 |
| 26 | MP0001905_abnormal_dopamine_level | 2.22137662 |
| 27 | MP0001529_abnormal_vocalization | 2.19637826 |
| 28 | MP0005423_abnormal_somatic_nervous | 2.19377803 |
| 29 | MP0009745_abnormal_behavioral_response | 2.19169069 |
| 30 | MP0005330_cardiomyopathy | 2.18790691 |
| 31 | MP0003634_abnormal_glial_cell | 2.17988066 |
| 32 | MP0002734_abnormal_mechanical_nocicepti | 2.17471360 |
| 33 | MP0009046_muscle_twitch | 2.17392436 |
| 34 | MP0005171_absent_coat_pigmentation | 2.10540928 |
| 35 | MP0004142_abnormal_muscle_tone | 2.08212456 |
| 36 | MP0004742_abnormal_vestibular_system | 2.04433220 |
| 37 | MP0002063_abnormal_learning/memory/cond | 1.93101053 |
| 38 | MP0002972_abnormal_cardiac_muscle | 1.89902143 |
| 39 | MP0000733_abnormal_muscle_development | 1.86258711 |
| 40 | MP0002572_abnormal_emotion/affect_behav | 1.81710059 |
| 41 | MP0001440_abnormal_grooming_behavior | 1.80845292 |
| 42 | MP0001485_abnormal_pinna_reflex | 1.75693579 |
| 43 | MP0003632_abnormal_nervous_system | 1.71221023 |
| 44 | MP0000955_abnormal_spinal_cord | 1.69107465 |
| 45 | MP0005551_abnormal_eye_electrophysiolog | 1.65668514 |
| 46 | MP0008569_lethality_at_weaning | 1.62772566 |
| 47 | MP0002837_dystrophic_cardiac_calcinosis | 1.62612768 |
| 48 | MP0002229_neurodegeneration | 1.62203740 |
| 49 | MP0004510_myositis | 1.56128700 |
| 50 | MP0004215_abnormal_myocardial_fiber | 1.55285873 |
| 51 | MP0002882_abnormal_neuron_morphology | 1.54623946 |
| 52 | MP0003136_yellow_coat_color | 1.52699143 |
| 53 | MP0001970_abnormal_pain_threshold | 1.52360803 |
| 54 | MP0001968_abnormal_touch/_nociception | 1.52103118 |
| 55 | MP0004858_abnormal_nervous_system | 1.51407125 |
| 56 | MP0002067_abnormal_sensory_capabilities | 1.51401405 |
| 57 | MP0003879_abnormal_hair_cell | 1.50893522 |
| 58 | MP0004145_abnormal_muscle_electrophysio | 1.50243260 |
| 59 | MP0000462_abnormal_digestive_system | 1.49938539 |
| 60 | MP0002733_abnormal_thermal_nociception | 1.44381747 |
| 61 | MP0006036_abnormal_mitochondrial_physio | 1.40746381 |
| 62 | MP0001299_abnormal_eye_distance/ | 1.40562479 |
| 63 | MP0004484_altered_response_of | 1.39493828 |
| 64 | MP0000013_abnormal_adipose_tissue | 1.37943127 |
| 65 | MP0003631_nervous_system_phenotype | 1.37351303 |
| 66 | MP0002735_abnormal_chemical_nociception | 1.36718487 |
| 67 | MP0002066_abnormal_motor_capabilities/c | 1.35860633 |
| 68 | MP0000604_amyloidosis | 1.34502833 |
| 69 | MP0004134_abnormal_chest_morphology | 1.33357181 |
| 70 | MP0005623_abnormal_meninges_morphology | 1.33312954 |
| 71 | MP0000747_muscle_weakness | 1.29438027 |
| 72 | MP0005386_behavior/neurological_phenoty | 1.28683976 |
| 73 | MP0004924_abnormal_behavior | 1.28683976 |
| 74 | MP0002736_abnormal_nociception_after | 1.28597891 |
| 75 | MP0006138_congestive_heart_failure | 1.26503398 |
| 76 | MP0000751_myopathy | 1.24021427 |
| 77 | MP0002752_abnormal_somatic_nervous | 1.22751181 |
| 78 | MP0010630_abnormal_cardiac_muscle | 1.22414721 |
| 79 | MP0005409_darkened_coat_color | 1.22037723 |
| 80 | MP0005410_abnormal_fertilization | 1.20013126 |
| 81 | MP0003633_abnormal_nervous_system | 1.19555134 |
| 82 | MP0002090_abnormal_vision | 1.18257602 |
| 83 | MP0001963_abnormal_hearing_physiology | 1.16697758 |
| 84 | MP0002184_abnormal_innervation | 1.16400034 |
| 85 | MP0005646_abnormal_pituitary_gland | 1.11307487 |
| 86 | MP0005385_cardiovascular_system_phenoty | 1.10899605 |
| 87 | MP0001544_abnormal_cardiovascular_syste | 1.10899605 |
| 88 | MP0002557_abnormal_social/conspecific_i | 1.07636245 |
| 89 | MP0003705_abnormal_hypodermis_morpholog | 1.06162757 |
| 90 | MP0001501_abnormal_sleep_pattern | 1.02854188 |
| 91 | MP0002152_abnormal_brain_morphology | 1.02754353 |
| 92 | MP0000749_muscle_degeneration | 1.02297524 |
| 93 | MP0009780_abnormal_chondrocyte_physiolo | 0.99893463 |
| 94 | MP0001502_abnormal_circadian_rhythm | 0.98775745 |
| 95 | MP0002127_abnormal_cardiovascular_syste | 0.95511982 |
| 96 | MP0010678_abnormal_skin_adnexa | 0.95268840 |
| 97 | MP0004811_abnormal_neuron_physiology | 0.94968092 |
| 98 | MP0002971_abnormal_brown_adipose | 0.93565873 |
| 99 | MP0005195_abnormal_posterior_eye | 0.91943873 |
| 100 | MP0001346_abnormal_lacrimal_gland | 0.89797360 |
| 101 | MP0006072_abnormal_retinal_apoptosis | 0.87876250 |
| 102 | MP0004147_increased_porphyrin_level | 0.87475399 |
| 103 | MP0004043_abnormal_pH_regulation | 0.87169291 |
| 104 | MP0005266_abnormal_metabolism | 0.85717077 |
| 105 | MP0000026_abnormal_inner_ear | 0.84354111 |
| 106 | MP0004036_abnormal_muscle_relaxation | 0.84146570 |
| 107 | MP0005253_abnormal_eye_physiology | 0.83927667 |
| 108 | MP0001958_emphysema | 0.83123507 |
| 109 | MP0001177_atelectasis | 0.83046865 |
| 110 | MP0006276_abnormal_autonomic_nervous | 0.82718326 |
| 111 | MP0000762_abnormal_tongue_morphology | 0.82537793 |
| 112 | MP0000566_synostosis | 0.82431794 |
| 113 | MP0000003_abnormal_adipose_tissue | 0.82199616 |
| 114 | MP0000383_abnormal_hair_follicle | 0.82094419 |
| 115 | MP0005645_abnormal_hypothalamus_physiol | 0.81680720 |
| 116 | MP0009250_abnormal_appendicular_skeleto | 0.80978635 |
| 117 | MP0005670_abnormal_white_adipose | 0.80441887 |
| 118 | MP0003938_abnormal_ear_development | 0.80324708 |
| 119 | MP0005167_abnormal_blood-brain_barrier | 0.77519750 |
| 120 | MP0002822_catalepsy | 0.77279630 |
| 121 | MP0010030_abnormal_orbit_morphology | 0.76553850 |
| 122 | MP0004085_abnormal_heartbeat | 0.75997142 |
| 123 | MP0005375_adipose_tissue_phenotype | 0.75555728 |
| 124 | MP0008438_abnormal_cutaneous_collagen | 0.75408481 |
| 125 | MP0002295_abnormal_pulmonary_circulatio | 0.75363624 |
| 126 | MP0004185_abnormal_adipocyte_glucose | 0.73544003 |
| 127 | MP0003137_abnormal_impulse_conducting | 0.71210396 |
| 128 | MP0003279_aneurysm | 0.70883013 |
| 129 | MP0001984_abnormal_olfaction | 0.70743189 |
| 130 | MP0000647_abnormal_sebaceous_gland | 0.69732266 |
| 131 | MP0008775_abnormal_heart_ventricle | 0.68291029 |
| 132 | MP0005666_abnormal_adipose_tissue | 0.67837324 |
| 133 | MP0003937_abnormal_limbs/digits/tail_de | 0.66784769 |
| 134 | MP0000631_abnormal_neuroendocrine_gland | 0.64388463 |
| 135 | MP0002108_abnormal_muscle_morphology | 0.63761231 |
| 136 | MP0001348_abnormal_lacrimal_gland | 0.63402033 |
| 137 | MP0001943_abnormal_respiration | 0.63007671 |
| 138 | MP0001664_abnormal_digestion | 0.61765010 |
| 139 | MP0003075_altered_response_to | 0.61200385 |
| 140 | MP0003045_fibrosis | 0.60586735 |
| 141 | MP0005058_abnormal_lysosome_morphology | 0.60562791 |
| 142 | MP0003861_abnormal_nervous_system | 0.60232895 |
| 143 | MP0003221_abnormal_cardiomyocyte_apopto | 0.60163129 |
| 144 | MP0008874_decreased_physiological_sensi | 0.59715630 |
| 145 | MP0005451_abnormal_body_composition | 0.59257308 |
| 146 | MP0005165_increased_susceptibility_to | 0.54169258 |
| 147 | MP0005166_decreased_susceptibility_to | 0.53344169 |
| 148 | MP0005535_abnormal_body_temperature | 0.51587704 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Type 1 muscle fiber predominance (HP:0003803) | 7.87544184 |
| 2 | Exercise-induced muscle cramps (HP:0003710) | 6.69641613 |
| 3 | Neurofibrillary tangles (HP:0002185) | 5.82427893 |
| 4 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 5.60129736 |
| 5 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 5.60129736 |
| 6 | Myopathic facies (HP:0002058) | 5.39957515 |
| 7 | Distal arthrogryposis (HP:0005684) | 5.07837759 |
| 8 | EMG: myopathic abnormalities (HP:0003458) | 4.99804066 |
| 9 | Calf muscle hypertrophy (HP:0008981) | 4.74390789 |
| 10 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 4.57577821 |
| 11 | Cerebral inclusion bodies (HP:0100314) | 4.43973815 |
| 12 | Abnormality of skeletal muscle fiber size (HP:0012084) | 4.40222901 |
| 13 | Abnormality of the corticospinal tract (HP:0002492) | 4.32847452 |
| 14 | Myoglobinuria (HP:0002913) | 4.25303733 |
| 15 | Rhabdomyolysis (HP:0003201) | 4.23580063 |
| 16 | Ulnar deviation of the wrist (HP:0003049) | 4.20122833 |
| 17 | Abnormality of the calf musculature (HP:0001430) | 4.18884908 |
| 18 | Neck muscle weakness (HP:0000467) | 4.15362114 |
| 19 | Myokymia (HP:0002411) | 4.06410787 |
| 20 | Sensory axonal neuropathy (HP:0003390) | 4.05495421 |
| 21 | Supranuclear gaze palsy (HP:0000605) | 3.94445501 |
| 22 | Distal lower limb muscle weakness (HP:0009053) | 3.92143753 |
| 23 | Increased variability in muscle fiber diameter (HP:0003557) | 3.83947476 |
| 24 | Increased connective tissue (HP:0009025) | 3.81520184 |
| 25 | Peripheral hypomyelination (HP:0007182) | 3.76969459 |
| 26 | Subaortic stenosis (HP:0001682) | 3.75395158 |
| 27 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.75395158 |
| 28 | Difficulty running (HP:0009046) | 3.70629874 |
| 29 | Muscle stiffness (HP:0003552) | 3.63058626 |
| 30 | Parakeratosis (HP:0001036) | 3.56439732 |
| 31 | Calcaneovalgus deformity (HP:0001848) | 3.52905814 |
| 32 | Rimmed vacuoles (HP:0003805) | 3.48474506 |
| 33 | Sudden death (HP:0001699) | 3.47341892 |
| 34 | Cerebral hypomyelination (HP:0006808) | 3.44609054 |
| 35 | Asymmetric septal hypertrophy (HP:0001670) | 3.44524809 |
| 36 | Spastic gait (HP:0002064) | 3.44502397 |
| 37 | Myotonia (HP:0002486) | 3.42535328 |
| 38 | Megalencephaly (HP:0001355) | 3.41122306 |
| 39 | Bundle branch block (HP:0011710) | 3.38872808 |
| 40 | Dysmetria (HP:0001310) | 3.20204177 |
| 41 | Ankle clonus (HP:0011448) | 3.19413190 |
| 42 | Frequent falls (HP:0002359) | 3.17673149 |
| 43 | Insidious onset (HP:0003587) | 3.17093731 |
| 44 | Termporal pattern (HP:0011008) | 3.17093731 |
| 45 | Deformed tarsal bones (HP:0008119) | 3.16559863 |
| 46 | Onion bulb formation (HP:0003383) | 3.11597971 |
| 47 | Retinal dysplasia (HP:0007973) | 3.10424134 |
| 48 | Mildly elevated creatine phosphokinase (HP:0008180) | 3.04358493 |
| 49 | Intention tremor (HP:0002080) | 3.01853941 |
| 50 | EMG: neuropathic changes (HP:0003445) | 3.00939516 |
| 51 | Focal motor seizures (HP:0011153) | 2.95488333 |
| 52 | Absent phalangeal crease (HP:0006109) | 2.93846561 |
| 53 | Alacrima (HP:0000522) | 2.91210799 |
| 54 | Distal lower limb amyotrophy (HP:0008944) | 2.87325873 |
| 55 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.84305274 |
| 56 | Aplasia involving bones of the extremities (HP:0009825) | 2.81058003 |
| 57 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.81058003 |
| 58 | Aplasia of the phalanges of the hand (HP:0009802) | 2.81058003 |
| 59 | Areflexia of lower limbs (HP:0002522) | 2.80580298 |
| 60 | Abnormality of glycolysis (HP:0004366) | 2.78973360 |
| 61 | Increased serum pyruvate (HP:0003542) | 2.78973360 |
| 62 | Slender build (HP:0001533) | 2.78046217 |
| 63 | Akinesia (HP:0002304) | 2.74734549 |
| 64 | Spinal rigidity (HP:0003306) | 2.68381580 |
| 65 | Scanning speech (HP:0002168) | 2.64412158 |
| 66 | Epileptic encephalopathy (HP:0200134) | 2.63485430 |
| 67 | Malignant hyperthermia (HP:0002047) | 2.61310723 |
| 68 | Hypoplastic pelvis (HP:0008839) | 2.61107827 |
| 69 | Lower limb amyotrophy (HP:0007210) | 2.59585208 |
| 70 | Abnormal auditory evoked potentials (HP:0006958) | 2.58274820 |
| 71 | Clumsiness (HP:0002312) | 2.56735506 |
| 72 | Atonic seizures (HP:0010819) | 2.53238094 |
| 73 | Generalized muscle weakness (HP:0003324) | 2.53185644 |
| 74 | Slow saccadic eye movements (HP:0000514) | 2.52483409 |
| 75 | Leukodystrophy (HP:0002415) | 2.50492269 |
| 76 | Bulbar palsy (HP:0001283) | 2.50260211 |
| 77 | Scapular winging (HP:0003691) | 2.50049186 |
| 78 | Pheochromocytoma (HP:0002666) | 2.47906087 |
| 79 | Difficulty climbing stairs (HP:0003551) | 2.43682781 |
| 80 | Action tremor (HP:0002345) | 2.38821993 |
| 81 | Limb-girdle muscle atrophy (HP:0003797) | 2.34877940 |
| 82 | Heart block (HP:0012722) | 2.34214729 |
| 83 | Lower limb muscle weakness (HP:0007340) | 2.32364274 |
| 84 | Abnormal finger flexion creases (HP:0006143) | 2.32315575 |
| 85 | Abnormal atrioventricular conduction (HP:0005150) | 2.32100400 |
| 86 | Weak cry (HP:0001612) | 2.29311024 |
| 87 | Dilated cardiomyopathy (HP:0001644) | 2.28954317 |
| 88 | Ventricular tachycardia (HP:0004756) | 2.23361534 |
| 89 | Decreased lacrimation (HP:0000633) | 2.22928542 |
| 90 | Focal seizures (HP:0007359) | 2.21194033 |
| 91 | Thickened helices (HP:0000391) | 2.20397932 |
| 92 | Neuroendocrine neoplasm (HP:0100634) | 2.15655890 |
| 93 | Spastic paraparesis (HP:0002313) | 2.13792657 |
| 94 | Increased circulating renin level (HP:0000848) | 2.13237531 |
| 95 | Urinary urgency (HP:0000012) | 2.13110868 |
| 96 | Coronal craniosynostosis (HP:0004440) | 2.11385901 |
| 97 | Infantile muscular hypotonia (HP:0008947) | 2.10314559 |
| 98 | CNS hypomyelination (HP:0003429) | 2.10195474 |
| 99 | Lipoatrophy (HP:0100578) | 2.09800446 |
| 100 | Split foot (HP:0001839) | 2.08199826 |
| 101 | Muscle fiber splitting (HP:0003555) | 2.06931377 |
| 102 | Humeroradial synostosis (HP:0003041) | 2.06859177 |
| 103 | Synostosis involving the elbow (HP:0003938) | 2.06859177 |
| 104 | Absent septum pellucidum (HP:0001331) | 2.06667589 |
| 105 | Hip contracture (HP:0003273) | 2.06185035 |
| 106 | Nemaline bodies (HP:0003798) | 2.04820279 |
| 107 | Type II lissencephaly (HP:0007260) | 2.03238456 |
| 108 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.03174887 |
| 109 | Stridor (HP:0010307) | 2.02280409 |
| 110 | Waddling gait (HP:0002515) | 2.01532416 |
| 111 | Abnormality of the calcaneus (HP:0008364) | 1.97215361 |
| 112 | Foot dorsiflexor weakness (HP:0009027) | 1.95972429 |
| 113 | Premature skin wrinkling (HP:0100678) | 1.95495896 |
| 114 | Progressive cerebellar ataxia (HP:0002073) | 1.93953447 |
| 115 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.93177036 |
| 116 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.93050824 |
| 117 | Muscle fiber inclusion bodies (HP:0100299) | 1.92573726 |
| 118 | Hyporeflexia of lower limbs (HP:0002600) | 1.91823603 |
| 119 | Muscular dystrophy (HP:0003560) | 1.90655669 |
| 120 | Anteriorly placed anus (HP:0001545) | 1.90000952 |
| 121 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 1.89904487 |
| 122 | Limb-girdle muscle weakness (HP:0003325) | 1.89569091 |
| 123 | Gowers sign (HP:0003391) | 1.88194346 |
| 124 | Fatigable weakness (HP:0003473) | 1.87606923 |
| 125 | Abnormality of the neuromuscular junction (HP:0003398) | 1.87606923 |
| 126 | Morphological abnormality of the inner ear (HP:0011390) | 1.87418024 |
| 127 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.87383049 |
| 128 | Ventricular arrhythmia (HP:0004308) | 1.87374724 |
| 129 | Bowel incontinence (HP:0002607) | 1.86701297 |
| 130 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.85068210 |
| 131 | Broad-based gait (HP:0002136) | 1.83415880 |
| 132 | Autoamputation (HP:0001218) | 1.83153220 |
| 133 | Round ear (HP:0100830) | 1.82586162 |
| 134 | Partial agenesis of the corpus callosum (HP:0001338) | 1.82248701 |
| 135 | Dysdiadochokinesis (HP:0002075) | 1.81374852 |
| 136 | Poor speech (HP:0002465) | 1.81069417 |
| 137 | Progressive muscle weakness (HP:0003323) | 1.80738570 |
| 138 | Abnormality of the middle phalanges of the toes (HP:0010183) | 1.80261065 |
| 139 | Hyperkalemia (HP:0002153) | 1.79819041 |
| 140 | Proximal amyotrophy (HP:0007126) | 1.79657222 |
| 141 | Clonus (HP:0002169) | 1.79142419 |
| 142 | Generalized myoclonic seizures (HP:0002123) | 1.78296485 |
| 143 | Vaginal atresia (HP:0000148) | 1.76701858 |
| 144 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.76665970 |
| 145 | Hammertoe (HP:0001765) | 1.76256549 |
| 146 | Exercise-induced myalgia (HP:0003738) | 1.75664731 |
| 147 | Abnormality of the foot musculature (HP:0001436) | 1.75510035 |
| 148 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.75016227 |
| 149 | Achilles tendon contracture (HP:0001771) | 1.74402031 |
| 150 | Hypoplasia of the iris (HP:0007676) | 1.73084277 |
| 151 | Cerebral hemorrhage (HP:0001342) | 1.71818306 |
| 152 | Genital tract atresia (HP:0001827) | 1.69710195 |
| 153 | Abnormal large intestine physiology (HP:0012700) | 1.69568960 |
| 154 | Ragged-red muscle fibers (HP:0003200) | 1.68354429 |
| 155 | Distal sensory impairment (HP:0002936) | 1.68094367 |
| 156 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 1.67740406 |
| 157 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.67620304 |
| 158 | Nonprogressive disorder (HP:0003680) | 1.67521809 |
| 159 | Abnormality of the septum pellucidum (HP:0007375) | 1.66191212 |
| 160 | Urinary incontinence (HP:0000020) | 1.65493613 |
| 161 | Obstructive sleep apnea (HP:0002870) | 1.65445210 |
| 162 | Dialeptic seizures (HP:0011146) | 1.64171231 |
| 163 | Fetal akinesia sequence (HP:0001989) | 1.63636800 |
| 164 | Steppage gait (HP:0003376) | 1.61989477 |
| 165 | Paraparesis (HP:0002385) | 1.61559688 |
| 166 | Decreased motor nerve conduction velocity (HP:0003431) | 1.61171095 |
| 167 | Atrioventricular block (HP:0001678) | 1.59750811 |
| 168 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.56827344 |
| 169 | Abnormality of the hip-girdle musculature (HP:0001445) | 1.56827344 |
| 170 | Ventricular fibrillation (HP:0001663) | 1.54896658 |
| 171 | Metatarsus adductus (HP:0001840) | 1.54701957 |
| 172 | Rapidly progressive (HP:0003678) | 1.52896739 |
| 173 | Limited hip movement (HP:0008800) | 1.52334919 |
| 174 | Abnormality of the Achilles tendon (HP:0005109) | 1.51062484 |
| 175 | Generalized tonic-clonic seizures (HP:0002069) | 1.50943991 |
| 176 | Generalized amyotrophy (HP:0003700) | 1.50042791 |
| 177 | Shoulder girdle muscle weakness (HP:0003547) | 1.47405550 |
| 178 | Exercise intolerance (HP:0003546) | 1.46235891 |
| 179 | Pelvic girdle muscle weakness (HP:0003749) | 1.41255843 |
| 180 | Diplopia (HP:0000651) | 1.39920883 |
| 181 | Abnormality of binocular vision (HP:0011514) | 1.39920883 |
| 182 | Congenital hip dislocation (HP:0001374) | 1.39492663 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TTN | 5.45132620 |
| 2 | STK39 | 5.22906207 |
| 3 | OXSR1 | 3.93577430 |
| 4 | EPHB1 | 2.83608068 |
| 5 | TNIK | 2.60339613 |
| 6 | CDK19 | 2.59469879 |
| 7 | BCR | 2.33864005 |
| 8 | EPHA4 | 2.28212531 |
| 9 | PKN1 | 2.17759041 |
| 10 | LIMK1 | 2.06765959 |
| 11 | WNK4 | 2.00609066 |
| 12 | MAPKAPK5 | 1.98944498 |
| 13 | PIK3CG | 1.94366822 |
| 14 | CASK | 1.91137816 |
| 15 | PRPF4B | 1.90114868 |
| 16 | NTRK1 | 1.85489082 |
| 17 | UHMK1 | 1.81201832 |
| 18 | PNCK | 1.80213185 |
| 19 | PAK6 | 1.78680116 |
| 20 | PHKG1 | 1.71205428 |
| 21 | PHKG2 | 1.71205428 |
| 22 | MARK1 | 1.65820174 |
| 23 | FGFR2 | 1.62925010 |
| 24 | PBK | 1.59783315 |
| 25 | MET | 1.59454043 |
| 26 | WNK1 | 1.57641201 |
| 27 | RIPK1 | 1.57388532 |
| 28 | ROCK2 | 1.54767872 |
| 29 | NEK6 | 1.51334944 |
| 30 | ICK | 1.48290931 |
| 31 | FGR | 1.47292846 |
| 32 | MAP2K3 | 1.45730072 |
| 33 | CAMK2B | 1.44267548 |
| 34 | NTRK2 | 1.41508728 |
| 35 | TESK2 | 1.36174958 |
| 36 | CSNK1G3 | 1.33823653 |
| 37 | SGK494 | 1.32867398 |
| 38 | SGK223 | 1.32867398 |
| 39 | NTRK3 | 1.30292845 |
| 40 | TYRO3 | 1.29164919 |
| 41 | CSNK1A1L | 1.24858567 |
| 42 | CSNK1G2 | 1.18855349 |
| 43 | CAMK2D | 1.17849734 |
| 44 | MAP2K4 | 1.17843733 |
| 45 | MAP3K7 | 1.15593752 |
| 46 | TRIB3 | 1.15465558 |
| 47 | CDK5 | 1.12544167 |
| 48 | LATS2 | 1.12406413 |
| 49 | PAK3 | 1.11976299 |
| 50 | MAPK13 | 1.09884987 |
| 51 | MOS | 1.09131893 |
| 52 | TESK1 | 1.08033059 |
| 53 | CDK14 | 1.07900854 |
| 54 | MAP3K9 | 1.07356804 |
| 55 | MAPKAPK3 | 1.05515356 |
| 56 | CAMK2G | 1.02926322 |
| 57 | MINK1 | 1.00269941 |
| 58 | CDK15 | 0.98094777 |
| 59 | MUSK | 0.97984970 |
| 60 | CAMK2A | 0.97621772 |
| 61 | CSNK1G1 | 0.96296330 |
| 62 | CDK18 | 0.95092449 |
| 63 | KSR2 | 0.93570245 |
| 64 | AKT3 | 0.90831634 |
| 65 | CAMK1 | 0.89129093 |
| 66 | DDR2 | 0.88760952 |
| 67 | MAP3K4 | 0.88654315 |
| 68 | PRKD3 | 0.88627892 |
| 69 | CDK11A | 0.87371921 |
| 70 | MAP3K11 | 0.86522712 |
| 71 | LMTK2 | 0.86424477 |
| 72 | MARK2 | 0.84462191 |
| 73 | ARAF | 0.83994805 |
| 74 | OBSCN | 0.79359909 |
| 75 | DYRK2 | 0.76887367 |
| 76 | CLK1 | 0.76385016 |
| 77 | PLK2 | 0.76228128 |
| 78 | MST4 | 0.75936095 |
| 79 | DYRK1B | 0.74843280 |
| 80 | MAP2K7 | 0.74207223 |
| 81 | TAOK2 | 0.72311689 |
| 82 | CAMK4 | 0.69763529 |
| 83 | PRKCE | 0.68020406 |
| 84 | SGK3 | 0.67782309 |
| 85 | PDPK1 | 0.66741943 |
| 86 | MAP2K6 | 0.65943218 |
| 87 | PRKCQ | 0.64289135 |
| 88 | IRAK2 | 0.64282426 |
| 89 | NME1 | 0.62761925 |
| 90 | SIK1 | 0.60693247 |
| 91 | CCNB1 | 0.60272630 |
| 92 | AKT2 | 0.59994661 |
| 93 | DMPK | 0.58709882 |
| 94 | PRKD1 | 0.57488878 |
| 95 | FYN | 0.57069055 |
| 96 | MAP3K2 | 0.55574604 |
| 97 | DAPK2 | 0.55103568 |
| 98 | EEF2K | 0.53544093 |
| 99 | PRKCG | 0.53431541 |
| 100 | MAPK4 | 0.52773601 |
| 101 | GRK5 | 0.52604299 |
| 102 | ROCK1 | 0.52135264 |
| 103 | MAP2K1 | 0.51626602 |
| 104 | PRKAA1 | 0.51398888 |
| 105 | PDGFRA | 0.51323289 |
| 106 | PINK1 | 0.50429527 |
| 107 | STK38 | 0.50329278 |
| 108 | PTK2B | 0.50302915 |
| 109 | MAP3K1 | 0.49415591 |
| 110 | PRKCH | 0.48422258 |
| 111 | DYRK1A | 0.47240589 |
| 112 | CAMKK1 | 0.46745439 |
| 113 | MYLK | 0.46477815 |
| 114 | CAMK1G | 0.46292603 |
| 115 | MAPK10 | 0.46117183 |
| 116 | SGK2 | 0.44801898 |
| 117 | PRKG1 | 0.43699434 |
| 118 | BMPR1B | 0.43568847 |
| 119 | NEK9 | 0.43254560 |
| 120 | PIK3CA | 0.42450343 |
| 121 | STK11 | 0.41966187 |
| 122 | PRKAA2 | 0.41641003 |
| 123 | BCKDK | 0.41422514 |
| 124 | MAP3K13 | 0.40878523 |
| 125 | DAPK3 | 0.40237330 |
| 126 | SGK1 | 0.39818387 |
| 127 | MAPK12 | 0.39537253 |
| 128 | BMX | 0.39421388 |
| 129 | BRAF | 0.39208296 |
| 130 | MAPK7 | 0.38595675 |
| 131 | RPS6KA3 | 0.37707879 |
| 132 | PRKACB | 0.37208268 |
| 133 | CSNK1A1 | 0.36411144 |
| 134 | TRPM7 | 0.34433964 |
| 135 | CSNK1D | 0.34270107 |
| 136 | PTK2 | 0.33952830 |
| 137 | PDK1 | 0.33709499 |
| 138 | ABL2 | 0.31397814 |
| 139 | PRKACA | 0.31190573 |
| 140 | PAK1 | 0.30801294 |
| 141 | RPS6KA2 | 0.29491362 |
| 142 | NEK1 | 0.28619039 |
| 143 | PRKD2 | 0.28518620 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 4.57509112 |
| 2 | Steroid biosynthesis_Homo sapiens_hsa00100 | 3.93234935 |
| 3 | Fatty acid elongation_Homo sapiens_hsa00062 | 3.18059525 |
| 4 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 3.17368136 |
| 5 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.00174960 |
| 6 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.95977936 |
| 7 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.44641589 |
| 8 | Ether lipid metabolism_Homo sapiens_hsa00565 | 2.25358068 |
| 9 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.10853096 |
| 10 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.05338356 |
| 11 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.92814445 |
| 12 | Axon guidance_Homo sapiens_hsa04360 | 1.88461138 |
| 13 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.84788143 |
| 14 | GABAergic synapse_Homo sapiens_hsa04727 | 1.84762986 |
| 15 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.81759859 |
| 16 | Circadian rhythm_Homo sapiens_hsa04710 | 1.77473277 |
| 17 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.77167631 |
| 18 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.73673290 |
| 19 | Nicotine addiction_Homo sapiens_hsa05033 | 1.66147394 |
| 20 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.65355150 |
| 21 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.63853786 |
| 22 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.56076608 |
| 23 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.55676043 |
| 24 | Morphine addiction_Homo sapiens_hsa05032 | 1.51049620 |
| 25 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.50719477 |
| 26 | Carbon metabolism_Homo sapiens_hsa01200 | 1.50201898 |
| 27 | Circadian entrainment_Homo sapiens_hsa04713 | 1.45235255 |
| 28 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.44080835 |
| 29 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.40465638 |
| 30 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.39928244 |
| 31 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.34906991 |
| 32 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.33880839 |
| 33 | Salivary secretion_Homo sapiens_hsa04970 | 1.32637768 |
| 34 | Alzheimers disease_Homo sapiens_hsa05010 | 1.31181549 |
| 35 | Parkinsons disease_Homo sapiens_hsa05012 | 1.27883622 |
| 36 | Long-term depression_Homo sapiens_hsa04730 | 1.27618144 |
| 37 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.27208016 |
| 38 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.22891706 |
| 39 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.21258829 |
| 40 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.20091887 |
| 41 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.19670639 |
| 42 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.17900007 |
| 43 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.17655403 |
| 44 | Phototransduction_Homo sapiens_hsa04744 | 1.16748060 |
| 45 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.16468133 |
| 46 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.14603585 |
| 47 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.12005921 |
| 48 | Olfactory transduction_Homo sapiens_hsa04740 | 1.11043969 |
| 49 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.10227537 |
| 50 | Cocaine addiction_Homo sapiens_hsa05030 | 1.01860678 |
| 51 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.00940616 |
| 52 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.00903694 |
| 53 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.99840422 |
| 54 | Protein export_Homo sapiens_hsa03060 | 0.99488758 |
| 55 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.97375007 |
| 56 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.96841545 |
| 57 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.95143254 |
| 58 | Tight junction_Homo sapiens_hsa04530 | 0.95047823 |
| 59 | Long-term potentiation_Homo sapiens_hsa04720 | 0.93782331 |
| 60 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.93538889 |
| 61 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.91764668 |
| 62 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.91416673 |
| 63 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.90309205 |
| 64 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.89172627 |
| 65 | Glioma_Homo sapiens_hsa05214 | 0.88187228 |
| 66 | Insulin resistance_Homo sapiens_hsa04931 | 0.88164426 |
| 67 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.88133038 |
| 68 | Gap junction_Homo sapiens_hsa04540 | 0.87082237 |
| 69 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.87021615 |
| 70 | Insulin secretion_Homo sapiens_hsa04911 | 0.86840341 |
| 71 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.86718570 |
| 72 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.85419888 |
| 73 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.83938474 |
| 74 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.83417839 |
| 75 | Renin secretion_Homo sapiens_hsa04924 | 0.82554507 |
| 76 | Focal adhesion_Homo sapiens_hsa04510 | 0.82420157 |
| 77 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.82308484 |
| 78 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.81420245 |
| 79 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.81022595 |
| 80 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.81002452 |
| 81 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.80232177 |
| 82 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.80141177 |
| 83 | Taste transduction_Homo sapiens_hsa04742 | 0.79489650 |
| 84 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.78136917 |
| 85 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.77158517 |
| 86 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.75939019 |
| 87 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.75619496 |
| 88 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.72439625 |
| 89 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.71276213 |
| 90 | Endocytosis_Homo sapiens_hsa04144 | 0.71123982 |
| 91 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.68878096 |
| 92 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.68143667 |
| 93 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.66612342 |
| 94 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.65638724 |
| 95 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.65172808 |
| 96 | Prion diseases_Homo sapiens_hsa05020 | 0.65092331 |
| 97 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.64949364 |
| 98 | Melanogenesis_Homo sapiens_hsa04916 | 0.63783911 |
| 99 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.63409268 |
| 100 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.61863728 |
| 101 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.61726776 |
| 102 | Huntingtons disease_Homo sapiens_hsa05016 | 0.60929760 |
| 103 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.60456254 |
| 104 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.59832823 |
| 105 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.59552434 |
| 106 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.59312570 |
| 107 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.59296563 |
| 108 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.57486591 |
| 109 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.56039218 |
| 110 | Lysosome_Homo sapiens_hsa04142 | 0.56007724 |
| 111 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.55711506 |
| 112 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.55162951 |
| 113 | Bile secretion_Homo sapiens_hsa04976 | 0.55112685 |
| 114 | Mineral absorption_Homo sapiens_hsa04978 | 0.54792626 |
| 115 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.53148200 |
| 116 | Histidine metabolism_Homo sapiens_hsa00340 | 0.52911563 |
| 117 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.52289432 |
| 118 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.52271314 |
| 119 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.51536501 |
| 120 | Galactose metabolism_Homo sapiens_hsa00052 | 0.50553153 |
| 121 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.49982348 |
| 122 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.49372133 |
| 123 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.48889700 |
| 124 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.46745437 |
| 125 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.45857813 |
| 126 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.45336489 |
| 127 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.43994691 |
| 128 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.43178135 |
| 129 | Phagosome_Homo sapiens_hsa04145 | 0.43049146 |
| 130 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.42618298 |
| 131 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.42052856 |
| 132 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.39517102 |
| 133 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.39406210 |
| 134 | Amoebiasis_Homo sapiens_hsa05146 | 0.38973566 |
| 135 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.38114408 |
| 136 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.37992133 |
| 137 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.37836688 |
| 138 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.37621055 |
| 139 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.34216285 |
| 140 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.34109915 |
| 141 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.32066363 |

